05/28/2026
The American Society of Clinical Oncology (ASCO) is where cutting-edge oncology meets patient care.
Ahead of , we’re highlighting the MODERN trial, which investigates the use of circulating tumor DNA to guide post-cystectomy immunotherapy in urothelial cancer.
Watch the IRB-approved video:
https://www.primrmed.com/cancer-clinical-trials/modern-trial
Produced in collaboration with Alliance for Clinical Trials in Oncology | Natera | National Cancer Institute (NCI)